You are here
Home 🌿 Recreational Marijuana News 🌿 A new study reveals that high-potency weed won't actually get stoners any higher than regular weed 🌿A new study reveals that high-potency weed won't actually get stoners any higher than regular weed
Warning message
The subscription service is currently unavailable. Please try again later.While the generally held assumption is that high-potency weed — say with a lofty THC count — will produce a higher high, a new study suggests that isn’t actually the case.
Researchers from the University of Colorado, Boulder looked to see if physical and cognitive impairment among regular cannabis users varies based on THC blood concentration. Touted as the first study to assess the acute impact of cannabis among real-world users of legal market products, it involved randomly assigning higher- or lower-THC products to 121 users. Participants used weed they had bought on their own and consumed it in their homes before being tested.
Beyond drawing participants’ blood, their mood and intoxication levels were assessed, and their cognitive function and balance tested before, directly after and an hour after they had consumed weed.
The findings?
Smoking high-potency marijuana will boost blood levels of THC more than twice as much as conventional weed, but it doesn’t get you higher.
“Surprisingly, we found that potency did not track with intoxication levels,” said lead author Cinnamon Bidwell, an assistant professor in the Institute of Cognitive Science. “While we saw striking differences in blood levels between the two groups, they were similarly impaired.”
Cognitive function and balance was tested before, directly after and an hour after they had consumed weed. / Photo: happyphoton / iStock / Getty Images Plus / Photo: happyphoton / iStock / Getty Images Plus
High-potency cannabis users showed similar neurobehavioral patterns to regular users, as well as comparable verbal memory and postural stability.
“People in the high concentration group were much less compromised than we thought they were going to be,” says co-author Kent Hutchison, a professor of psychology and neuroscience at the university. “If we gave people that high a concentration of alcohol it would have been a different story,” Hutchison says.
It’s not clear why there wasn’t greater intoxication among the concentrate group. Possible factors include tolerance or genetic differences that make some users metabolize THC more quickly. Or it may be that once cannabinoids “fill receptors in the brain that spark intoxication, additional cannabinoids have little impact,” the researchers note.
Despite the lack of differences in high- and low-THC cannabis, Bidwell says the findings indicate that using concentrates could unnecessarily put people at greater long-term risk of side-effects. “It raises a lot of questions about how quickly the body builds up tolerance to cannabis and whether people might be able to achieve desired results at lower doses.”
Maybe lower-potency, cheaper weed is a better bang for the buck.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.